Details for New Drug Application (NDA): 213906
✉ Email this page to a colleague
NDA 213906 describes LEVORPHANOL TARTRATE, which is a drug marketed by Hikma, Novitium Pharma, Specgx Llc, Sun Pharm Inds Inc, and Virtus, and is included in five NDAs. It is available from six suppliers. Additional details are available on the LEVORPHANOL TARTRATE profile page.
The generic ingredient in LEVORPHANOL TARTRATE is levorphanol tartrate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levorphanol tartrate profile page.
The generic ingredient in LEVORPHANOL TARTRATE is levorphanol tartrate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levorphanol tartrate profile page.
Summary for 213906
| Tradename: | LEVORPHANOL TARTRATE |
| Applicant: | Sun Pharm Inds Inc |
| Ingredient: | levorphanol tartrate |
| Patents: | 0 |
Pharmacology for NDA: 213906
| Mechanism of Action | Full Opioid Agonists |
Medical Subject Heading (MeSH) Categories for 213906
Suppliers and Packaging for NDA: 213906
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LEVORPHANOL TARTRATE | levorphanol tartrate | TABLET;ORAL | 213906 | ANDA | Sun Pharmaceutical Industries, Inc. | 57664-058 | 57664-058-88 | 100 TABLET in 1 BOTTLE (57664-058-88) |
| LEVORPHANOL TARTRATE | levorphanol tartrate | TABLET;ORAL | 213906 | ANDA | Sun Pharmaceutical Industries, Inc. | 57664-762 | 57664-762-88 | 100 TABLET in 1 BOTTLE (57664-762-88) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Jun 17, 2021 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 3MG | ||||
| Approval Date: | Apr 25, 2023 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
